Yes, chemotherapy can cause weight gain, and it’s more common than many people expect. Between 50% and 96% of breast cancer patients receiving chemotherapy experience some degree of weight gain, with an average increase of 3 to 5 kilograms (roughly 7 to 11 pounds). The gain isn’t limited to breast cancer treatment either, though that’s where the most research exists. Several overlapping mechanisms drive the increase, from fluid retention to hormonal shifts to the steroids given alongside chemo drugs.
How Common Weight Gain Is During Chemo
Weight gain during chemotherapy varies widely from person to person. In large studies of breast cancer patients, more than one third gained over 5% of their starting body weight within the first year of treatment. That level of gain persisted over time: similar proportions were still above the 5% threshold at 5, 10, and even 13 years after starting treatment. In one U.S.-based study, 35% of patients had gained more than 2 kilograms after two years.
Not everyone gains the same amount. Some people gain only a couple of pounds, while others gain significantly more. A Turkish study following 176 women on anthracycline-based regimens found 72% had gained weight by the end of year one, with a median gain of about 3 kilograms. Among African American breast cancer survivors, 47% reported weight gain after treatment, with individual gains ranging from about 5.5 to nearly 14 pounds across different studies. The type of chemotherapy, the duration of treatment, and your body’s individual response all play a role.
Why Chemo Causes Weight Gain
There’s no single explanation. Weight gain during chemotherapy results from several overlapping factors, and distinguishing between them matters because the solutions differ.
Fluid Retention
One of the most immediate causes is edema, or fluid buildup in your tissues. Certain chemo drugs, particularly platinum-based agents, can damage the kidneys and reduce their ability to clear fluid efficiently. Chemotherapy can also affect the heart and blood vessels, leading to fluid retention through cardiovascular changes like high blood pressure or weakened heart function. You might notice swelling in your ankles, feet, hands, or legs. The skin in swollen areas can look puffy or shiny, and pressing on it may leave a temporary dent. This type of weight gain can appear quickly and fluctuate from day to day.
Steroid Premedication
Most chemo regimens include steroids like dexamethasone, given before infusions to prevent nausea and allergic reactions. These steroids increase appetite, raise blood sugar, and promote fat storage. In a study of breast cancer patients in Mexico, higher cumulative dexamethasone doses roughly doubled the odds of significant weight gain. The effect is dose-dependent: the more steroid you receive over the course of treatment, the greater the risk.
Hormonal Changes
For premenopausal women, chemotherapy can damage the ovaries and trigger early menopause. The resulting drop in estrogen slows metabolism and shifts where your body stores fat. Even in women who are already postmenopausal, the hormonal therapies often prescribed alongside chemo (particularly aromatase inhibitors, used in about 70% to 80% of hormone receptor-positive breast cancers) further disrupt the metabolic profile, especially lipid metabolism. These hormonal shifts make the body more efficient at storing calories as fat and less efficient at burning them.
Reduced Physical Activity
Fatigue is one of the most common side effects of chemotherapy. When you’re exhausted, nauseated, or dealing with pain, daily movement drops. That decrease in activity burns fewer calories, but it also accelerates muscle loss, which lowers your resting metabolic rate. Over weeks and months of treatment, this creates a widening gap between the calories your body needs and the calories it stores.
The Hidden Shift: Muscle Loss With Fat Gain
One of the more concerning aspects of chemo-related weight change is that your body composition can shift dramatically even if the number on the scale barely moves. Chemotherapy drugs cause oxidative stress in muscle tissue, leading to progressive loss of lean muscle mass. At the same time, fat mass increases and fat deposits build up within the muscle itself. This combination, sometimes called sarcopenic obesity, means you can weigh the same or more while being physically weaker and metabolically less healthy.
This matters beyond appearance. Loss of muscle mass is linked to greater fatigue, reduced physical function, and poorer treatment tolerance. Because standard scales don’t differentiate between muscle and fat, the true extent of body composition change often goes unrecognized. If your clothes fit differently or you feel weaker even though your weight hasn’t changed much, this shift in muscle-to-fat ratio is likely part of the explanation.
Which Treatments Are Most Linked to Weight Gain
Weight gain is most strongly correlated with cytotoxic (cell-killing) chemotherapy rather than other cancer treatments like surgery or radiation alone. Among the regimens most studied, cyclophosphamide-based combinations appear frequently. Older protocols that included longer treatment durations and prednisone as part of the regimen were associated with the most pronounced gains. Modern anthracycline-based regimens (with or without taxanes) still produce measurable weight gain in the majority of patients, though the gains tend to be somewhat smaller than those seen with older protocols.
The pattern holds across different regimen types. Studies tracking patients on anthracycline-only regimens, anthracycline-plus-taxane regimens, and older non-anthracycline combinations all documented weight gain, suggesting the problem is not limited to a single drug class.
Fluid Weight vs. Fat Weight
Distinguishing between fluid retention and actual fat gain is important because they require different approaches. Fluid-related weight gain tends to appear quickly, sometimes within days of a treatment cycle. It shows up as visible swelling, particularly in the lower legs and feet. If you press on the swollen area and a dimple or pit remains for a few seconds before the skin rebounds, that’s a hallmark of fluid-based edema. This type of gain can fluctuate significantly and may resolve between treatment cycles or after treatment ends.
Fat-based weight gain accumulates more gradually over weeks and months. It tends to distribute around the midsection (especially when driven by hormonal changes or steroids) and doesn’t cause the puffy, shiny skin characteristic of edema. Many patients experience both types simultaneously, which makes the total number on the scale particularly frustrating to interpret.
Managing Weight During Treatment
Preventing weight gain during chemotherapy is more realistic than trying to lose it afterward. Research on diet and exercise interventions during treatment suggests that a combination of moderate physical activity and dietary changes can help.
On the nutrition side, a low-fat diet rich in fruits and vegetables has shown promise. One structured program set targets of 7 to 8 servings of fruits and vegetables per day, with fat intake limited to about 15% of total calories. These aren’t extreme restrictions. The goal is to provide nutrient-dense food that satisfies hunger from steroid-driven appetite increases without excessive calorie intake.
For physical activity, 30 minutes per day of moderate activity (walking, gentle cycling, stretching) is considered both effective and achievable during treatment. This doesn’t need to happen all at once, and the intensity can be adapted to how you’re feeling on any given day. The key benefit isn’t just calorie burning. Regular movement helps preserve muscle mass, which is critical given chemo’s tendency to break down lean tissue. Even modest activity protects against the muscle-to-fat shift that underlies much of the long-term metabolic damage.
Because steroid doses are an independent risk factor for weight gain, some oncology teams are working to minimize the cumulative amount of dexamethasone used across treatment cycles. If you’re noticing significant appetite surges on steroid days, tracking what and how much you eat during those windows can help you recognize the pattern and plan for it.
How Long the Weight Tends to Last
For many patients, the weight gained during chemotherapy does not simply disappear when treatment ends. Long-term tracking studies show that more than a third of breast cancer patients still carry excess weight 13 years after starting chemotherapy. The proportion of patients above the 5% weight gain threshold remains remarkably stable over time, from roughly 35% at year one to 37% at year 13. This suggests that the metabolic and body composition changes triggered during treatment create a new baseline that the body resists moving away from without active intervention.
The persistence of this weight gain likely reflects the lasting effects of muscle loss, hormonal changes (especially in women pushed into early menopause), and the metabolic consequences of increased fat mass. Weight gained from fluid retention is more likely to resolve after treatment, but fat-based and composition-based changes tend to stick.